New epilepsy drug tested as solo treatment for partial seizures
NCT ID NCT06453213
First seen Sep 30, 2025 · Last updated May 01, 2026 · Updated 25 times
Summary
This study tests cenobamate, an approved seizure drug, when used alone in adults with newly diagnosed or recurrent partial-onset epilepsy. About 49 participants will take either 100 mg or 200 mg daily to see if they become seizure-free for 26 weeks. The goal is to gather more data on how well cenobamate works as a standalone treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOCAL ONSET SEIZURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Arizona Neuroscience Research
Phoenix, Arizona, 85032, United States
-
Bluegrass Epilepsy Research LLC
Lexington, Kentucky, 40504, United States
-
Center For Neurosciences
Tucson, Arizona, 85718, United States
-
Clinical Trials Inc
Little Rock, Arkansas, 72205, United States
-
Consultants In Epilepsy and Neurology
Boise, Idaho, 83702, United States
-
DHR Health Institute for Research and Development
Edinburg, Texas, 78539, United States
-
Elite Clinical Research
Miami, Florida, 33144, United States
-
Hartford Hospital
Hartford, Connecticut, 06102, United States
-
Henry Ford Health System
Detroit, Michigan, 48202, United States
-
Hoag Physician Partners
Newport Beach, California, 92663, United States
-
John Hopkins Epilepsy Center
Baltimore, Maryland, 21287, United States
-
Knight Neurology
Rockledge, Florida, 32955, United States
-
Louisiana State University Health Sciences
Shreveport, Louisiana, 71103, United States
-
Mount Sinai Hospital
New York, New York, 10029, United States
-
NY Neurology Associates
New York, New York, 10003, United States
-
Neuro Pain Medical Center
Fresno, California, 93710, United States
-
University of Missouri Health Care
Columbia, Missouri, 65212, United States
-
Wayne Neurology PLC
Plymouth, Michigan, 48170, United States
-
Yale School of Medicine - Yale-New Haven Hospital
New Haven, Connecticut, 06519, United States
Conditions
Explore the condition pages connected to this study.